Delivery Order SPE2DB20D1100-SPE2DB25FE0R0
- Not listed
- The Defense Logistics Agency awarded a $1,872.48 delivery order to AmerisourceBergen Drug Corp for Belbuca 600 microgram films (60 count) under a firm fixed price contract type. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,027.72 to AmerisourceBergen Drug Corp for BELBUCA 150 MCG film (60 units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award utilized firm fixed pricing and required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,301.28 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Belbuca 450 mcg film, with an ultimate completion date of September 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. Belbuca is a buccal film formulation used for pain management in opioid-tolerant patients. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of BELBUCA 450 micrograms film in a quantity of 60 units, valued at $1,301.28. This non-set-aside, firm fixed-price delivery order has an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film in a quantity of 60 units, with a ceiling value of $1,053.12. This firm fixed price contract, awarded on July 23, 2025, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of Belbuca 600 MCG Film in quantities of 60 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,121.71 and an ultimate completion date of August 19, 2025. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's logistics organization responsible for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0R0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains a $999.999 billion indefinite delivery contract (SPE2DX) with DLA through December 2026, which enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare systems globally. Belbuca is a buprenorphine transmucosal film used for pain management, falling within the pharmaceutical product categories that AmerisourceBergen routinely delivers through its DLA contracts. This delivery order exemplifies the company's role as a prime vendor in the federal medical supply chain, fulfilling individual medication orders that support Defense Health Agency operations and other government healthcare systems. The competitively awarded contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement standards through open competition across its extensive portfolio of pharmaceutical and medical supply deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/14/25 |